LOLLO Giovanna

Spécialité :

Génie Pharmaceutique

Compétences :

Design and development of novel drug delivery nanosystems to overcome physiological barriers for the treatment of various diseases.

Bureau : G119

Téléphone : 04 72 44 85 84

EMail

25 documents

  • Annalisa Rosso, Eyad Almouazen, Jorge Pontes, Valentina Andretto, Marine Leroux, et al.. Supersaturable self-microemulsifying delivery systems: an approach to enhance oral bioavailability of benzimidazole anticancer drugs. Drug Delivery and Translational Research, Springer, 2021, ⟨10.1007/S13346-021-00904-X⟩. ⟨hal-03175653⟩
  • Ilaria Andreana, Mathieu Repellin, Flavia Carton, David Kryza, Stephanie Briancon, et al.. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics, MDPI, 2021, 13 (2), pp.278. ⟨10.3390/pharmaceutics13020278⟩. ⟨hal-03151769⟩
  • Valentina Andretto, Annalisa Rosso, Stephanie Briancon, Giovanna Lollo. Nanocomposite systems for precise oral delivery of drugs and biologics. Drug Delivery and Translational Research, Springer, 2021, ⟨10.1007/s13346-021-00905-w⟩. ⟨hal-03135470⟩
  • Mathieu Borel, Giovanna Lollo, David Magne, René Buchet, Leyre Brizuela, et al.. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2020, 1866 (12), pp.165919. ⟨10.1016/j.bbadis.2020.165919⟩. ⟨hal-02925416⟩
  • Molood Shariati, Giovanna Lollo, Kevin Matha, Benedicte Descamps, Christian Vanhove, et al.. Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer. ACS Applied Materials & Interfaces, Washington, D.C. : American Chemical Society, 2020, ⟨10.1021/acsami.0c05554⟩. ⟨hal-02862066⟩
  • Julien Bompard, Annalisa Rosso, Leyre Brizuela, Saïda Mebarek, Loïc Blum, et al.. Membrane Fluidity as a New Means to Selectively Target Cancer Cells with Fusogenic Lipid Carriers. Langmuir, American Chemical Society, 2020, 36 (19), pp.5134-5144. ⟨10.1021/acs.langmuir.0c00262⟩. ⟨hal-03083631⟩
  • Annalisa Rosso, Giovanna Lollo, Yves Chevalier, Nam Troung, Claire Bordes, et al.. Development and structural characterization of a novel nanoemulsion for oral drug delivery. Colloids and Surfaces A: Physicochemical and Engineering Aspects, Elsevier, 2020, 593, pp.124614. ⟨10.1016/j.colsurfa.2020.124614⟩. ⟨hal-02841383⟩
  • Julien Bompard, Annalisa Rosso, Leyre Brizuela Madrid, Saida Mebarek, Loïc Jacques Blum, et al.. Membrane Fluidity as a New Mean to Selectively Target Cancer Cells with Fusogenic Lipid Carriers. Langmuir, American Chemical Society, 2020, ⟨10.1021/acs.langmuir.0c00262⟩. ⟨hal-02566508⟩
  • Giovanna Lollo, Jean-Pierre Benoit, Marie Brachet-Botineau. Drug delivery system for platinum-based drugs. France, Patent n° : WO 2020/053445 A1. 2020. ⟨hal-03142927⟩
  • Francesca Rolle, Valeria Bincoletto, Elena Gazzano, Barbara Rolando, Giovanna Lollo, et al.. Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells. International Journal of Pharmaceutics, Elsevier, 2020, pp.119191. ⟨10.1016/j.ijpharm.2020.119191⟩. ⟨hal-02498380⟩